Who does what in a packaging project, roles and decision ownership

During a pharmaceutical packaging project, multiple stakeholders provide input, but a single individual must own each key decision. This is the most practical approach to defining who does what. When ownership is clear, teams move faster because approvals, evidence gathering, and subsequent steps are much easier to manage. Conversely, when the owner is unclear, processes like artwork review, specification freezes, and trial acceptance often slow down.

This article offers a practical look at pharmaceutical packaging development by highlighting typical contributors, identifying who should make the final decisions, and demonstrating how a simple responsibility matrix helps at every project gate. It also clarifies where packaging project roles and responsibilities frequently overlap, enabling your team to avoid unnecessary delays and costly rework.

• Clear ownership is crucial because contributors are not the same as approvers.

• A simple responsibility matrix helps pharma teams separate daily work, final approvals, general input, and routine updates.

• The three most common stall points are the pack format freeze decision, final artwork approval, and line trial acceptance.

• Establishing a primary point of contact with the packaging supplier can minimize handovers, though formal approvals always remain with the customer.

• QA packaging release must remain within the agreed-upon quality system and approved process.

Who does what in a packaging project starts with one owner per decision

Packaging projects frequently stall when multiple departments review the same topic, yet no one has the final say. This can occur even if the technical work is completed on schedule. For example, a line trial might finish exactly as planned, but the project halts because a line trial acceptance owner was never designated beforehand. In such cases, the delay stems from poor governance rather than any issue with the machine or the packaging itself.

A strong starting point is simple: one decision requires one accountable owner. Teams should absolutely still gather input from the supply chain, procurement, packaging engineering, QA, regulatory affairs, product management, and their packaging partner. However, the project requires one specific person or defined function to approve the final outcome. This principle is the cornerstone of packaging project governance and the primary reason why well-defined roles matter.

The problem with shared input and no clear owner

Shared input is valuable because packaging impacts product fit, machine performance, approved text, supply reliability, and the release flow. Nevertheless, shared input cannot replace definitive ownership. If everyone comments on the artwork but no one actually approves the final controlled version, review loops stretch on, and version control inevitably weakens. The same issue arises when tooling is ready for release, but the packaging specification owner remains undefined.

Many teams assume the project manager will solve this simply by chasing down action items. In practice, while a project manager can facilitate the process, they are rarely the final approver for technical or quality decisions. Because of this, the approval path must be clearly established long before a critical decision point arrives.

A plain-language responsibility matrix

Using a RACI model for packaging projects is highly effective because it transforms vague discussions about roles into a practical, actionable map. 'Responsible' refers to the person or team executing the work. 'Accountable' denotes the individual who signs off and ultimately owns the final decision. 'Consulted' applies to those who provide expert input before an approval is granted, while 'Informed' covers the people who need to be notified of the result after a decision is finalized.

In regulated environments, approval flows are often more complex. There may be additional roles, such as a checker, a verifier, or a formal signatory. Therefore, any simple responsibility chart must accurately reflect the real processes dictated by the customer and their quality management system. If the chart appears straightforward but the actual approval sequence is convoluted, the project can easily stall.

• Responsible: Does the actual work and prepares the required output.

• Accountable: Approves the output and takes ownership of the final decision.

• Consulted: Provides expert input before any approval is granted.

• Informed: Receives notification of the decision and acts upon the result if necessary.

A simple decision-making view teams can use

Many teams find it helpful to map out the most critical project gates in plain language. For instance, achieving a frozen specification might list packaging engineering as 'responsible,' one specific packaging specification owner as 'accountable,' QA and the supply chain as 'consulted,' and operations as 'informed.' Similarly, artwork approval could assign artwork management as 'responsible,' one designated final approver as 'accountable,' product, QA, and regulatory teams as 'consulted,' and the supply chain as 'informed.' For trial acceptance, engineering or operations might be 'responsible' for the report, a dedicated line trial acceptance owner would be 'accountable,' QA and technical functions would be 'consulted,' and the wider team 'informed.'

Who does what in a packaging project across the customer team

Supply chain and procurement

The supply chain team typically focuses on supply reliability, forecast alignment, production planning, and daily issue handling. Meanwhile, procurement generally manages commercial terms, supplier strategies, and contracts. While these roles are essential, they are fundamentally different from technical ownership. A supplier contract can comfortably sit with procurement, while the technical packaging definition remains with an entirely different functional group.

This distinction is a common source of confusion when defining packaging project roles and responsibilities. Procurement can absolutely own the commercial relationship without acting as the packaging specification owner. Splitting these duties works well because it ensures technical approval remains with the experts who assess physical fit, manufacturing tolerances, machinability, and controlled documentation changes.

Packaging engineer

The packaging engineer usually leads the technical definition of the pack. Their scope covers material selection, dimensions, tolerances, product compatibility, line fit, and overall ease of production. In most projects, this role is the natural owner of the technical package definition. Even so, the customer must explicitly name the accountable owner long before the pack format freeze decision takes place.

Early technical input is vital because late-stage design changes are incredibly difficult to manage. When manufacturability and component fit are reviewed early on, the team can significantly reduce rework before artwork, tooling, and trials progress too far. This proactive approach is often much easier with expert support in pharma packaging design and development, allowing line fit and component interactions to be thoroughly verified prior to freezing the specification.

Project manager

The project manager is responsible for keeping the overall plan moving forward. Their duties include timeline tracking, dependency management, meeting coordination, risk mitigation, and issue escalation. They typically own the decision log and ensure that every project gate has a designated owner, a strict deadline, and the appropriate supporting evidence. This role is central to packaging project governance, as it bridges various workstreams that might otherwise drift out of alignment.

A strong project manager also establishes a clear fallback route. If a primary owner is unexpectedly absent during a critical phase, such as artwork approval week, the team should already know who is authorized to step in via an approved proxy process. This ensures that a single absence does not snowball into a broader project control issue.

Product manager, QA, and regulatory affairs

The product manager typically advocates for the medication itself, focusing on patient needs, packaging purpose, and broader business priorities. The quality assurance (QA) team handles quality decisions, controlled process steps, and QA packaging releases under the agreed-upon system. Regulatory affairs manages approved texts, specific country requirements, submission timelines, and the overall impact of any changes. These three roles are intimately linked, particularly during the artwork review and approval phases.

A very common question is who ultimately approves packaging artwork. In most projects, input from product, QA, and regulatory teams is absolutely necessary. However, providing comments is not the same as granting formal approval. The team must still designate a single accountable signatory for the final controlled version. While the exact person will depend on internal company procedures, the role must be formally defined well before the file reaches the final approval stage.

Who does what in a packaging project across the packaging partner team

The partner's technical counterpart

On the packaging partner's side, a technical counterpart supports design development, component feasibility, tooling assumptions, and line compatibility. This individual provides essential drawings, trial insights, and production feedback to help the customer make well-informed decisions. Because this valuable input is provided early, it minimizes late-stage changes and allows the customer to assess risks thoroughly before the specification freeze.

Importantly, this support does not replace the customer's internal owner. Instead, it strengthens the foundational evidence the customer team relies upon. A responsibility matrix works exceptionally well in this scenario, clearly showing how the partner supports the decision-making process without transferring formal accountability away from the customer.

The packaging supplier point of contact

Having a dedicated point of contact at the packaging supplier can streamline communication across design, in-house component production, packing operations, and equipment support. This is especially vital when multiple workstreams are advancing simultaneously and the customer prefers to minimize handovers. A single contact allows the project manager to track progress more efficiently, as all updates flow through one clear, unified channel.

It is important to note that this contact does not sign off on behalf of the customer. Their primary value lies in coordination and project continuity. Readers seeking more context on how named counterparts operate can meet the packaging team to see exactly how a well-structured contact system fosters smoother collaboration.

Full chain support and workstream coordination

Certain projects benefit immensely from utilizing a single partner across a broader scope, simply because there are fewer external interfaces to manage. We actively support design, ease of production, in-house component manufacturing, primary and secondary packing including serialization, and the provision of packaging equipment for customers who prefer to insource. This comprehensive approach dramatically reduces handovers and makes troubleshooting far more direct, as fewer parties need to align at every step.

Even with end-to-end support, customer accountability remains entirely explicit. Formal ownership of specification approvals, release steps, and internal sign-offs strictly resides with the customer, following their agreed-upon internal processes. While our primary and secondary packaging solutions cover an extensive supply chain, it remains critical to define precisely who owns each gate within that journey.

Who does what in a packaging project at the three decisions that most often stall

Who owns the pack format freeze decision?

The pack format freeze decision frequently slows down simply because so many stakeholders care deeply about the outcome. Engineering might focus entirely on physical fit and tolerances, while product managers prioritize patient usability. The supply chain team might only look at lead times, and the packaging partner will present evidence regarding tooling, packing efficiency, and line performance. While all of this input is incredibly helpful, one single customer owner must step forward to approve the frozen specification.

A practical example is a wallet pack that works beautifully in concept but still requires concrete proof regarding component fit and packing performance. During this phase, consulted functions must challenge the design before it freezes. Once the final evidence is thoroughly reviewed, one designated owner must approve the specification so that artwork, tooling, and trials can confidently move forward under strict control.

Who approves packaging artwork?

Artwork approval is another classic bottleneck, largely because a vast number of comments tend to flood the file. Product, QA, and regulatory teams all need to review the text, layout, specific market requirements, and release logic. Even with this collaborative review, the project absolutely requires one final approver for the controlled version. This strict accountability is the only way a team can maintain clear version control and close the project gate on time.

This stage highlights exactly why teams must separate contributors from approvers. A contributor can raise a valid comment or request a text correction. Conversely, an approver formally accepts the final file against the agreed-upon regulatory process. Whenever the line between these two roles blurs, endless review rounds occur, and the project inevitably loses valuable time.

Who is the line trial acceptance owner?

The line trial acceptance owner must be officially named well before the trial even begins. Furthermore, the trial should run strictly against pre-agreed criteria, such as machine performance, overall pack integrity, code quality, reject rates, and physical handling at key stations. If these criteria remain vague, team members will end up arguing over the same results from entirely different perspectives, ultimately failing to reach a decision.

Consider a typical trial that successfully meets its output targets but simultaneously reveals minor handling concerns at a single station. In this scenario, the team urgently needs to know who holds the authority to accept the result, reject it outright, or mandate changes based on the data. This pivotal decision must follow the agreed-upon responsibility matrix, because a high volume of conflicting opinions does not equate to actual decision-making authority.

Who does what in a packaging project changes by project stage

Concept and development

At the concept stage, the primary focus is on the pack's purpose, early design choices, overall feasibility, and critical manufacturability input. During the subsequent development phase, the project transitions from a loose idea into a highly controlled definition. This is typically when the packaging specification owner becomes much more visible, as the pack must evolve from an abstract concept into a frozen, perfectly usable specification.

Responsibilities often shift dynamically during this stage. One specific function might initiate the early design work, while another department later becomes accountable for the final controlled specification. While this shift is perfectly normal, the transition in accountability must be entirely explicit. The whole team needs to know exactly when ownership shifts from creative exploration to formal approval.

Trial and qualification

During the trial and qualification phases, hard evidence matters far more than personal opinion. Acceptance criteria, change controls, formal trial reports, and approval routing must be crystal clear before any physical work begins. Otherwise, the team risks having to repeat costly trials simply because the initial results were difficult to judge or the final approver was never properly designated.

This stage naturally brings technical reviews and QA assessments much closer together. It is up to the project manager to proactively confirm who will prepare the final report, who will review the raw data, who serves as the formal line trial acceptance owner, and who simply requires a brief update once the results are finalized.

Commercial packing

Once a project enters commercial packing, the focus shifts heavily toward routine execution, product release flows, strict change control, and ongoing issue management. While roles might appear much more stable at this point, explicit ownership is still essential. Forecasts will inevitably change, artwork updates will be required, and unforeseen deviations will occasionally surface. Having a clear responsibility matrix ensures rapid, effective handling whenever a process strays from its normal path.

The responsibility for QA packaging release must stay firmly with the function outlined in the approved quality management system. It should never default to the purchasing department, nor should anyone assume it rests with the packaging partner unless a formal, documented process explicitly states otherwise. Enforcing this rule protects quality control and keeps the release pathway perfectly aligned with all agreed-upon responsibilities.

How accountability stays explicit at every gate

It is completely acceptable for the assigned owner to change from one project gate to the next. For instance, a technical lead might own the specification freeze, while a totally different department owns the final artwork approval. This makes sense, as different project stages require vastly different types of evidence and control. What truly matters is that accountability remains explicit every time the team approaches a formal decision point.

If your team requires a broader view of the entire process, our comprehensive guide on pharmaceutical packaging development explains exactly how project stages build over time, detailing why early strategic decisions heavily influence later quality control points.

Practical checklist for mapping packaging project roles and responsibilities

Questions to answer before artwork, tooling, and line decisions begin

Before any major work commences, the team must confirm a few critical points in writing. Doing so keeps the responsibility matrix highly practical and prevents costly confusion down the line. First, clarify exactly who owns the frozen packaging specification. Second, determine who will formally sign off on the final controlled artwork. Third, verify who serves as the designated line trial acceptance owner. From there, the team must outline which departments need to be consulted prior to approval, which groups merely need to be informed after a gate is passed, what specific evidence is required for each decision, and what the authorized fallback route is if the primary owner is suddenly unavailable.

These straightforward checks frequently prevent massive delays, simply because they force the entire team to clearly define authority long before project pressure begins to mount. In practice, this proactive alignment is one of the easiest, most effective ways to improve packaging project roles and responsibilities without cluttering the calendar with additional meetings.

When to review the matrix again

The responsibility matrix should be thoroughly reviewed again whenever the project scope changes, as well as right before artwork approval, tooling release, line trials, and the onset of commercial packing. These are the critical junctures where casual assumptions rapidly transform into formal commitments. A brief, focused review at each of these gates can save countless hours later, ensuring the team actively confirms ownership before the project ever reaches a dreaded stall point.

If your current project is still struggling with open questions regarding true ownership, approval flows, or complex handovers, you are more than welcome to discuss project roles and responsibilities directly with our experts. Bringing your existing decision map and a list of open issues will help make our discussion as practical and actionable as possible.

FAQ

Who approves packaging artwork in a pharmaceutical project?

While packaging artwork typically requires collaborative input from product management, QA, and regulatory affairs, a single final approver must officially sign off on the final controlled version. This unified approach keeps version control exceptionally clear and dramatically reduces the number of repeated review loops.

Can procurement own the supplier contract and not the specification?

Absolutely. Procurement can fully manage the contract, negotiate commercial terms, and dictate supplier strategy, all while the actual technical specification remains firmly with a dedicated technical or product owner. This clear separation of duties is very common in highly regulated packaging projects.

Who should be the packaging specification owner?

The customer must name one clearly accountable owner for the frozen packaging specification. In the vast majority of projects, this individual is the packaging engineer or another qualified technical lead. However, regardless of their title, the exact role and their authority must be defined as early as possible.

Does one packaging supplier point of contact replace customer approvals?

No. While a single supplier point of contact can effectively reduce external handovers and greatly simplify coordination across multiple workstreams, it does not replace internal oversight. All formal customer approvals, final sign-off duties, and QA release responsibilities remain strictly with the customer, operating in full accordance with their agreed-upon internal processes.

Who owns QA packaging release?

QA packaging release must always remain within the bounds of the agreed-upon quality management system and its formally approved processes. This responsibility should be owned exclusively by the function defined within that framework. It should never automatically shift to procurement, nor should it be delegated to a packaging partner without explicit, documented authorization.